#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14284	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2231	636.6	0	.	n	.	0	C451T	SNP	451	451	C	697	697	T	848	T,C	428,367	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14284	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2231	636.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1430	1430	C	820	C	769	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14284	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2231	636.6	0	HET	.	.	.	C199T	.	199	199	C	445	445	C	786	C,T	597,138	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26604	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3580	740.9	0	.	n	.	0	T695C	SNP	695	695	T	1025	1025	C	770	C	718	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26604	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3580	740.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2301	2301	C	888	C,A,T	811,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26604	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3580	740.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2375	2375	A	932	A	853	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26604	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3580	740.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2927	2927	C	810	C	752	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26604	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3580	740.9	0	HET	.	.	.	T707C	.	707	707	T	1037	1037	T	766	T,C	539,163	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1776	folP	855	855	100.0	folP.l15.c4.ctg.1	1445	122.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1000	1002	AGC	155;153;151	A;G;C	148;143;139	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5194	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3344	154.8	1	SNP	p	S91F	1	.	.	271	273	TTC	576	578	TTC	185;186;188	T;T,C;C	170;169,1;172	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5194	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3344	154.8	1	SNP	p	D95G	1	.	.	283	285	GGC	588	590	GGC	187;184;185	G;G,A;C	173;165,1;171	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5194	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3344	154.8	1	SNP	p	G95N	0	.	.	283	285	GGC	588	590	GGC	187;184;185	G;G,A;C	173;165,1;171	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1514	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1215	123.9	1	SNP	p	G45D	0	.	.	133	135	GGC	398	400	GGC	201;201;200	G;G;C	184;185;185	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	714	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1066	66.6	0	.	n	.	0	A197.	DEL	197	197	A	601	601	A	171	A	162	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5540	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3045	181.5	1	SNP	p	D86N	0	.	.	256	258	GAC	590	592	GAC	235;234;232	G;A,G;C	216;210,1;213	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5540	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3045	181.5	1	SNP	p	R87I	0	.	.	259	261	CGT	593	595	CGT	231;226;229	C;G,A;T	211;209,1;214	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5540	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3045	181.5	1	SNP	p	S87R	1	.	.	259	261	CGT	593	595	CGT	231;226;229	C;G,A;T	211;209,1;214	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5540	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3045	181.5	1	SNP	p	R87W	0	.	.	259	261	CGT	593	595	CGT	231;226;229	C;G,A;T	211;209,1;214	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5540	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3045	181.5	1	SNP	p	S88P	0	.	.	262	264	TCC	596	598	TCC	230;231;232	T;C;C	213;214;216	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4032	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2668	150.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1554	1556	GGC	190;193;194	G;G;C	173;174;174	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3798	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2346	161.3	1	SNP	p	A311V	0	.	.	931	933	GCC	1219	1221	GCC	191;195;193	G;C;C,T	179;184;180,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3798	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2346	161.3	1	SNP	p	I312M	1	.	.	934	936	ATG	1222	1224	ATG	193;192;196	A;T;G	181;182;185	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3798	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2346	161.3	1	SNP	p	V316T	1	.	.	946	948	ACC	1234	1236	ACC	206;203;203	A;C;C	191;186;186	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3798	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2346	161.3	1	SNP	p	T316P	0	.	.	946	948	ACC	1234	1236	ACC	206;203;203	A;C;C	191;186;186	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3798	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2346	161.3	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1735	1737	ACC	195;196;194	A;C,T;C,A	174;178,1;178,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3798	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2346	161.3	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1789	1791	GCG	193;191;189	G;C;G	176;175;177	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3798	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2346	161.3	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1789	1791	GCG	193;191;189	G;C;G	176;175;177	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3798	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2346	161.3	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1912	1914	GGT	193;193;197	G;G;T	177;179;177	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3798	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2346	161.3	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1921	1923	AGC	190;189;186	A,G;G;C	175,1;174;168	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3798	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2346	161.3	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1939	1941	CCG	150;155;156	C,G;C,G;G	107,7;113,2;121	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5832	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	3226	180.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1717	1719	CCG	219;221;219	C;C;G	195;199;198	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2350	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1662	140.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	544	544	C	165	C	154	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2854	porB1b	1038	1038	100.0	porB1b.l6.c30.ctg.1	1540	184.0	1	SNP	p	G120K	1	.	.	358	360	AAG	701	703	AAG	221;226;226	A;A;G	210;215;214	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2854	porB1b	1038	1038	100.0	porB1b.l6.c30.ctg.1	1540	184.0	1	SNP	p	N121D	0	.	.	361	363	AAC	704	706	AAC	227;226;230	A;A;C,A	215;215;216,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2854	porB1b	1038	1038	100.0	porB1b.l6.c30.ctg.1	1540	184.0	1	SNP	p	A121N	1	.	.	361	363	AAC	704	706	AAC	227;226;230	A;A;C,A	215;215;216,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10622	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4753	222.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1096	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1200	91.2	1	SNP	p	V57M	1	.	.	169	171	ATG	552	554	ATG	236;238;235	A;T;G,A	219;221;218,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
